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Microorganisms, particularly bacteria, are becoming resistant to more and more anti-
microbial agents. Bacteria found in hospitals appear to be especially resistant and are
causing increasing difficulties to patients. Bacterial resistance is currently combated by
the discovery of new drugs.
The Baylis-Hillman reaction is an important three-component reaction involving eco-
nomical construction of a carbon-carbon bond between the a-position of an activated-vinyl
molecule and an electrophile under the catalytic effect of a tertiary amine (most com-
monly 1,4-diazabicylo[2.2.2]octane, DABCO) and producing an interesting class of syn-
thetically useful densely functionalized molecules (1, 2). Baylis-Hillman adducts, contain-
ing chemo-specific functional groups in close proximity, have been extensively used in a
number of transformation methodologies (3–9). Recently, several Baylis-Hillman adducts
have been evaluated for molluscicidal activity against Biomphalaria glabrata (Say) snails,
the intermediate hosts of Schistosomiasis. Among these compounds, 3-hydroxy-2-methyl-
ene-3-(4'-nitrophenyl)propanonitrile (compound 4, Table I) had the highest activity, with
IC50 = 6.64 mg mL–1 (10). The 2-phenyl-5-amino-uracil derivative with the Baylis-Hill-
man side chain was found to display extremely interesting properties with regard to its
apoptosis-inducing ability in HL-60 cells (11). A new class of pyrimidinyl agents was syn-
thesized using the Baylis-Hillman strategy and some of these molecules displayed po-
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tent antimalarial activity against Plasmodium falciparum in vitro (12). Several Baylis-Hill-
man adducts were evaluated for antimalarial activity against chloroquine resistant P. fal-
ciparum and compound 4 was found to be the most active one (13). High selective leish-
manicidal activity of 3-hydroxy-2-methylene-3-(4’-bromophenyl)-propanonitrile and analo-
gous compounds has been reported as well (14).
Amphenicols (2-amino-3-phenyl-propane-1,3-diol derivatives), a class of antibacte-
rials including chloramphenicol and thiamphenicol, display a wide spectrum of antibac-
terial activity (15). Therefore, 3-hydroxy-2-methylene-3-phenylpropionic acid derivatives,
obtained by the Baylis-Hillman condensation, were evaluated for antimicrobial activity.
Though many Baylis-Hillman adducts are known, there is no previous report describing
the antimicrobial activity of these molecules. We report herein the antimicrobial activity
of 3-hydroxy-2-methylene-3-phenylpropionic acid derivatives.
EXPERIMENTAL
FT-IR spectra were recorded on FT-IR spectrometer (Spectrum One, Perkin-Elmer,
USA). 1H NMR spectra were recorded on 60 and 400 MHz spectrometers (EM 360 L and
Mercury Plus, respectively; Varian, USA) in CDCl3. Chemical shifts were measured as d
units (ppm) relative to tetramethylsilane and coupling constants are expressed in Hertz.
Microanalyses were performed in a Carlo Erba Model 1106 elemental analyzer. Silica gel
(100–200 mesh) used for column chromatography was activated by heating at 120 °C for
4 h. The purity of all compounds was established by a single spot on TLC plates (Merck,
Germany). Iodine vapours or anisaldehyde-sulfuric acid reagent were used as the devel-
oping agent and the solvent system used for TLC analysis was ethyl acetate and n-hex-
ane (2:8). Solvents were purified by standard procedures. All other chemicals used in the
study were of analytical grade.
Synthesis of 3-hydroxy-2-methylene-3-phenylpropionic acid derivatives 1–20 through
Baylis-Hillman reaction (10, 13). General procedure
Amixture of aromatic aldehyde (0.6 mmol), activated alkene (2.4 mmol) and DABCO
(0.06 mmol) was stirred at room temperature for the period mentioned in Table I. The
reaction mixture was diluted with ether (20 mL), washed with 5 mL of 2 mol L–1 HCl
and water. The organic layer was dried (anhydrous Na2SO4). Solvent was evaporated
and the residue was purified by column chromatography on silica gel. Corresponding
Baylis-Hillman adducts 1–20 were obtained in varying yields (Table I).
Antimicrobial activity
Minimum inhibitory concentration (MIC). – Broth dilution method was used to deter-
mine the MIC of test compounds. Stock solutions of compounds 1–20 were prepared by
dissolving 1 mg in 1 mL of DMSO and diluted to the desired concentration. Fresh cultures
of bacteria (Staphylococcus aureus, ATCC 9144; Corynebacterium diphtheriae, ATCC 27010;
Klebsiella pneumoniae, ATCC 10031; Escherichia coli, ATCC 10536) and fungi (Aspergillus niger,
ATCC 16404 and Candida albicans, ATCC 10231) were prepared. The antibacterial activity
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of each test compound was examined as follows: in the test tube containing Müller-Hinton
broth (Merck, Germany), a bacterial concentration of 5 × 105 colony forming units mL–1
was tested with 5–30 µg mL–1 (serial dilution) of test compounds. Moreover, a tube of
the Müller-Hinton broth containing the same bacterial concentration, but without test
compound, was used as growth control and another tube of uninoculated Müller-Hinton
broth containing the same concentration of test compound was used as negative growth.
Also, a tube of Müller-Hinton broth containing the same bacterial concentration and DMSO,
without test compound, was prepared as control to rule out antibacterial effect of DMSO.
Test tubes and three mentioned control tubes were incubated at 37 °C for 24 h. After in-
cubation, antibacterial activity of the test compound in the test tube was detected by lack
of turbidity (matching the negative growth control), which indicated inhibition of bacte-
rial growth. The turbidity was measured at 530 nm.
449
S. A. Singh and S. V. Bhat: Antimicrobial potential of 3-hydroxy-2-methylene-3-phenylpropionic acid derivatives, Acta Pharm. 61
(2011) 447–455.
Table I. 3-Hydroxy-2-methylene-3-phenylpropionic acid derivatives





1 H H H COOMe 2.00 50
2 H H H CN 2.00 67
3 H NO2 H COOMe 2.00 48
4 H NO2 H CN 0.08 53
5 NO2 H H COOMe 3.00 58
6 NO2 H H CN 3.00 62
7 H Cl H COOEt 2.00 62
8 H Cl H CN 2.00 72
9 OMe H H CN 3.00 69
10 OMe H H COOEt 3.00 65
11 H F H CN 2.50 66
12 H F H COOEt 2.50 65
13 Cl H H CN 2.00 69
14 Cl H H COOEt 3.00 68
15 Cl Cl H COOEt 3.00 64
16 Cl Cl H CN 3.00 64
17 H H NO2 COOEt 3.00 68
18 H H NO2 CN 4.00 68
19 H NO2 H COOEt 3.00 59
20 H Cl H COEt 3.00 54
RESULTS AND DISCUSSION
In the present work, various substituted benzaldehydes were condensed with acti-
vated vinyl derivatives in the presence of a catalytic amount of DABCO according to li-
terature procedures (10, 13) (Scheme 1). Various activated vinyl derivatives included ethyl
and methyl acrylates, acrylonitrile and ethyl-vinyl-ketone (Scheme 1). The reaction was
carried out at room temperature without solvent. The reaction time ranged from 2 to 4
days and 3-hydroxy-2-methylene-3-phenyl-propionic acid derivatives 1–20 were obtain-
ed in moderate to good yields (48–72 %, Table I).
The Baylis-Hillman adducts were characterized using IR, 1H NMR spectra and micro
analyses. IR spectra of compounds showed peaks at ~3450 and 1620 cm–1 (hydroxy and
vinyl group, respectively). In the 1H NMR, vinyl protons and allylic proton singlets ap-
peared at d 5.9–6.2 and ~5.3 ppm, respectively. In addition, 1H NMR of all molecules dis-
played characteristic peaks due to aromatic protons. Microanalyses of synthesized com-
pounds were in agreement with their molecular formula with ± 0.3 % (Table II).
Antibacterial activity and structure activity relationship
Antibacterial activity of the Baylis-Hillman adducts, namely 3-hydroxy-2-methy-
lene-3-phenylpropionic acid derivatives 1–20, was evaluated by the agar serial dilution
method (16) against the bacteria and fungi mentioned above. Minimum inhibitory con-
centrations (MIC, µg mL–1) of compounds for antibacterial and antifungal activities are
given in Table III.
Many of the test compounds displayed good antimicrobial activity; compounds 3–8
and 11–19, showed slighty higher to comparable antimicrobial activity to standard drugs.
Compounds 3-6, 15, 17 and 18 showed antimicrobial activity withMIC 14–16 µg mL–1 vs.
chloramphenicol (MIC 21 and 19 µg mL–1, respectively) against S. aureus and C. diphthe-
riae. These active compounds contained 2-, 3- or 4-nitro- (3–6, 17 and 18) or 2,4-dichloro (15)
substituents in the phenyl ring. Compounds 15 and 20 displayed antibacterial activity with
MIC 15–16 µg mL–1 vs. standard chloramphenicol (MIC 20 mg mL–1) against K. pneumoniae.
Both of these compounds contained 4-chloro-substituent in the phenyl ring. Compounds
7, 8, 12–14 and 17 containing 4-chloro- (7, 8), 4-fluoro- (12), 2-chloro- (13, 14) or 3-nitro-
(17) in the phenyl ring were potent against E. coli with MIC 15-16 µg mL–1 compared to
chloramphenicol (MIC 19 µg mL–1). Against A. niger compounds 5, 6 (2-nitro-), 7 (4-chlo-
ro-), 11 (4-fluoro) and 16 (2,4-dichloro-) with MIC 11 µg mL–1 displayed comparable anti-
fungal activity to that of nystatin (MIC 13 µg mL–1) and against C. albicans. Compounds
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7.50–7.20 (m, 5H, Ar-H),
6.31, 5.80 (s, 1H each, -C=CH2),
5.08 (s, 1H, allylic H),
3.70 (s, 3H, OMe),









7.50–7.20 (m, 5H, Ar-H),
6.10 (s, 2H -C=CH2),
5.83 (s, 1H, allylic H),









7.95 (d, J = 10 Hz, 2H, Ar-H),
7.55 (d, J = 10 Hz, 2H, Ar-H),
6.38, 5.90 (s, 1H each, -C=CH2),
5.62 (s, 1H, allylic H),
3.72 (s, 3H, OMe),









7.95 (d, J = 9 Hz, 2H, Ar-H),
7.60 (d, J = 9 Hz, 2H, Ar-H),
6.15 (s, 2H, -C=CH2),
5.48 (bs, 1H, allylic H),









7.45–7.75 (m, 4H, Ar-H),
6.60, 6.20 (s, 1H each, -C=CH2),
5.82 (s, 1H, allylic H),
5.20 (s, 3H, OMe),









7.90–7.2 (m, 4H, Ar-H),
6.35 (s, 2H, -C=CH2),
5.58 (bs, 1H, allylic H),









7.85 (d, J = 9 Hz, 2H, Ar-H),
7.35 (d, J = 9 Hz, 2H, Ar-H),
6.38, 5.95 (s, 1H, each, -C=CH2),
5.82 (s, 1H, allylic H),
4.20 (q, J = 7 Hz, 2H, -OCH2),
3.20 (bs, 1H, -OH),









7.95 (d, J = 9 Hz, 2H, Ar-H),
7.60 (d, J = 9 Hz, 2H, Ar-H),
6.38, 5.95 (s, 1H, each, -C=CH2),
5.58 (bs, 1H, allylic H),









7.95–7.60 (m, 4H, Ar-H),
6.18, 5.75 (s, 1H each, -C=CH2),
5.48 (bs, 1H, allylic H),
3.40 (s, 1H, -OH),












7.95–7.55 (m, 4H, Ar-H),
6.68, 6.12 (s, 1H each, -C=CH2),
5.85 (s, 1H, allylic-H),
4.20 (q, J = 7 Hz, 2H, -OCH2-),
3.62 (s, 3H, OMe),
3.05 (bs, 1H, -OH),









7.95 (m, 2H, Ar-H),
7.30 (d, J = 8.5 Hz, 2H, Ar-H),
6.35 (d, 2H, -C=CH2),
5.58 (bs, 1H, allylic H),









7.95 (m, 2H, Ar-H),
7.30 (d, J = 8.5 Hz, 2H, Ar-H),
6.60, 6.15 (s,1H, -C=CH2),
5.85 (s, 1H, allylic H),
4.42 (q, J = 7 Hz, 2H, -OCH2-),
3.20 (bs, 1H, -OH),









7.70–7.20 (m, 4H, Ar-H),
5.85 (s, 2H, -C=CH2),
5.28 (s, 1H, allylic H),









7.95–7.65 (m, 4H, Ar-H),
6.38, 5.90 (s, 1H each, -C=CH2),
5.82 (s, 1H, allylic H),
3.42 (q, J = 7 Hz, 2H, -OCH2-),
3.04 (bs, 1H, -OH),









8.85 (s, 1H, Ar-H),
7.70–7.45 (bd, 2H, Ar-H),
6.38, 5.90 (s, 1H each, -C=CH2),
5.82 (s, 1H, allylic H),
3.42 (q, J = 7 Hz, 2H, -OCH2-),
3.40 (bs, 1H, -OH),









7.85 (s, 1H, Ar-H),
7.70–7.45 (bd, 2H, Ar-H),
6.35 (s, 2H, -C=CH2),
5.08 (bs, 1H, allylic H),









8.45 (s, 1H, Ar-H),
8.40–7.70 (m, 3H, Ar-H),
6.48, 5.70 (s, 1H each, -C=CH2),
5.42 (s, 1H, allylic H),
3.72 (q, J = 7 Hz, 2H, -OCH2-),
3.04 (bs, 1H, -OH),












8.45 (s, 1H, Ar-H),
8.40–7.60 (m, 3H, Ar-H),
6.15 (s, 2H, -C=CH2),
5.28 (bs, 1H, allylic H),









7.75 (d, J = 10 Hz, 2H, Ar-H),
7.20 (d, J = 10 Hz, 2H, Ar-H),
5.95, 5.55 (s, 1H, each, -C=CH2),
5.08 (s, 1H, allylic H),









7.95 (d, J = 8.5 Hz, 2H, Ar-H),
7.70 (d, 2H, J = 8.5 Hz, Ar-H),
6.15, 5.70 (s, 1H each, olefinic H),
5.19 (bs, 1H, allylic H),
4.03 (q, J = 7 Hz, 2H, -OCH2),
3.04 (s, 1H, -OH),





Table III. Minimum inhibitory concentration (MIC) of compounds 1-20a
Compd. S. aureus C. diphtheriae K. pneumoniae E. coli A. niger C. albicans
1 – 25 30 22 – –
2 20 20 21 19 – –
3 16 14 18 17 – 13
4 15 15 20 17 12 12
5 16 14 18 17 11 12
6 15 15 20 17 11 13
7 18 16 18 15 11 12
8 16 19 18 16 12 13
9 – – 25 24 12 –
10 – – 22 21 – 12
11 18 18 20 17 11 13
12 20 19 18 16 14 15
13 18 18 18 16 14 13
14 18 18 18 16 14 13
15 16 15 15 18 13 11
16 18 17 18 20 11 15
17 16 14 18 16 13 14
18 16 14 18 17 14 10
19 18 18 17 18 12 11
20 18 18 16 20 13 12
Standardb 21 19 20 19 13 15
a µg mL–1
b Chloramphenicol and nystatin were used as reference standards for antibacterial and antifungal tests respectively.
15 (2,4-dichloro), 18 and 19 (3-nitro-) with MIC 10–11 µg mL–1 showed good antifungal
activity compared to nystatin (MIC 15 µg mL–1).
The adducts with 2-methoxy-substituent (9 and 10) did not display any antibacte-
rial activity but showed antifungal activity with MIC 12 µg mL–1 against A. niger and C.
albicans, respectively.
The compounds with 4-fluoro-substituent (11 and 12) and with 4-chloro-substituent
(7 and 8) displayed similar antibacterial and antifungal activities, whereas adducts 1 and
2, without any substituent in the phenyl ring, were devoid of antimicrobial activity.
CONCLUSIONS
Many among differently substituted 3-hydroxy-2-methylene-3-phenylpropionic acid
derivatives displayed good antimicrobial activity. Particularly, the 3-hydroxy-2-methy-
lene-3-phenylpropionic acid derivatives with 2-, 3- or 4-nitro- (3–6, 17–19), 2-chloro- (13, 14),
4-chloro (7, 8, 20), 4-fluoro- (11, 12) and 2,4-dichloro- (15, 16) substituents in the phenyl
ring helped in potent antibacterial and/or antifugal activities. The derivatives with 2-me-
thoxy substituent (9, 10) in the phenyl ring displayed only antifugal activity. The ease of
synthesis from low cost starting materials along with potent antimicrobial activity of
these molecules provide the lead for further improvement of activity and reflect the possi-
bility of therapeutic use.
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S A @ E T A K
Antimikrobno djelovanje derivata 3-hidroksi-2-metilen-3-fenilpropionske kiseline
SONI A. SINGH i SUJATA V. BHAT
Iz razli~itih aromatskih aldehida i aktiviranih vinil derivata sintetizirano je dvadeset
Baylis-Hillmanovih adukata, razli~ito supstituiranih derivata 3-hidroksi-2-metilen-3-fenil-
propionske kiseline. Ispitano je njihovo antimikrobno djelovanje in vitro metodom serijskih
razrje|enja. Ve}ina ispitivanih spojeva pokazala je sna`no antibakterijsko i antifungalno
djelovanje. Jednostavni sintetski postupak iz jeftinih sirovina i sna`no antimikrobno dje-
lovanje pru`aju vode}e spojeve za daljnju modifikaciju, koji mogu dovesti do ljekovitih
tvari pogodnih za terapijsku primjenu.
Klju~ne rije~i: derivati 3-hidroksi-2-metilen-3-fenilpropionske kiseline, antibakterijsko djelovanje, anti-
fungalno djelovanje, Baylis-Hillmanova reakcija
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